Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel Ni/C catalyst method for nadifloxacin intermediate. High yield, green process, reliable supply chain partner for pharmaceutical manufacturing.
Novel ionic liquid synthesis for YM-905 intermediate. High yield, low toxicity, scalable production for global supply chains.
Novel Pd-catalyzed process for Pamiparib intermediate BG-11. High chiral purity, reduced cost, scalable manufacturing for global supply chains.
Patent CN113603636A details a cost-effective Nickel-catalyzed route for 2-isopropyl-3-amino-4-methylpyridine, offering significant supply chain advantages.
Patent CN113999160B reveals a safer, cost-effective route for antiviral intermediates. Discover how this novel method reduces supply chain risks and manufacturing costs significantly.
Novel resolution-before-condensation route for Ramosetron HCl. Reduces N-methylindole consumption and boosts yield for scalable API manufacturing.
Patent CN104086475A details a high-purity one-pot synthesis route. This method offers substantial cost reduction in pharma manufacturing and ensures supply chain reliability for chiral intermediates.
Advanced solid-phase fragment synthesis for GpTx-1 and Analogue 71. High purity, scalable process for Nav1.7 pain therapeutics. Cost-effective manufacturing solution.
Patent CN102911109A reveals a scalable 4-step route for 6-amino-5-fluoro-1-isoindolinone, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN119431279B reveals a novel Ir-catalyzed asymmetric hydrogenation route for chiral cyclic ethers, offering superior purity and cost-effective manufacturing for pharmaceutical intermediates.
New synthesis method for AZD-3759 improves yield and safety. Cost reduction in pharmaceutical intermediates manufacturing via scalable routes.
Patent CN107915699A details a streamlined synthesis of Corallidictyal D. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101712705B details a robust synthetic route for apigenin glycosides, offering reliable supply chain solutions and cost reduction in pharmaceutical intermediate manufacturing.
Novel 3-step chemical synthesis of pseudouridine using 2,3,5-tribenzyloxy-D-ribono-1,4-lactone. High yield, scalable process for mRNA therapeutics and reliable supply.
Patent CN104059952A details immobilized cell catalysis for high-purity intermediates. This method offers significant cost reduction and supply chain reliability for global manufacturers.
Novel copper-palladium catalyzed route for 3-aryl pyrroles. Enhances purity and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN102532149A details a novel asymmetric synthesis for galanthamine and lycoramine. Discover cost-effective, scalable routes for high-purity API manufacturing.
Novel patent CN107176948A offers safer Pimobendan synthesis. Eliminating toxic reagents ensures supply chain reliability and cost reduction for pharmaceutical manufacturers.
Novel bidentate azacarbene manganese catalyst enables mild alkylation. Reduces cost and toxicity in pharmaceutical intermediate manufacturing.
Novel two-step synthesis method for Fenofibrate Impurity G ensures high purity and cost-effective supply chain solutions for pharmaceutical quality control.